Since its release just a few months ago, PyTorch 1.0 has been rapidly adopted as a powerful, flexible deep learning platform that enables engineers and researchers to move quickly from research to production…

Radiology. Autonomous vehicles. Supercomputing. The changes sweeping through all these fields are closely related. Just ask NVIDIA CEO Jensen Huang…

A Frederick National Laboratory for Cancer Research-founded organization has announced plans to partner with a California-based technology company to advance its artificial intelligence drug discovery program…

Nvidia is collaborating with medical groups to push GPU-powered AI tools into clinical settings, including radiology and drug discovery…

Nvidia Corp. reckons artificial intelligence has evolved to the point where it can be reliably used to help diagnose diseases and discover new drugs…

The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate of pharmaceutical research programs has inspired a surge of activity in this area over the last several years…

The recently established Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium, was conceived by John, with a mission “to accelerate the development of more effective therapies for patients”…

Since its launch in 2016, the Cancer Moonshot initiative has successfully united leading international scientists from industry and academia, whose collaborative efforts have been key to the delivery of more effective tools for cancer diagnosis, treatment and prevention…